Transcriptional activation of cyclooxygenase-2 by tumor suppressor p53 requires nuclear factor-kappaB

Oncogene

Volumn 25, Issue 42, 2006, Pages 5708-5718

  Benoit, V ^a   De Moraes, E ^b,e   Dar, N A ^b   Taranchon, E ^b   Bours, V ^a   Hautefeuille, A ^b   Taniere P ^b,c,f   Chariot, A ^a   Scoazec, J Y ^c   De Moura Gallo, C V ^d   Merville, M P ^a   Hainaut, P ^b  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c EDOUARD HERRIOT HOSPITAL   (France)

^d STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^e INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^f UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Barrett's metaplasia; Cyclooxygenase 2; Esophageal cancer; NF kappaB; p53

Indexed keywords

3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; CELECOXIB; CYCLOOXYGENASE 2; DAUNORUBICIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NIMESULIDE; PROTEIN P53; ROFECOXIB;

APOPTOSIS; ARTICLE; BARRETT ESOPHAGUS; CANCER CELL CULTURE; CELL SURVIVAL; COLON CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA DAMAGE; ENZYME INHIBITION; ESOPHAGUS CANCER; GENE INDUCTION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; INFLAMMATION; PRIORITY JOURNAL; PROMOTER REGION; SQUAMOUS CELL CARCINOMA; TRANSCRIPTION INITIATION; TUMOR SUPPRESSOR GENE; UPREGULATION;

CASPASES; CELL DIVISION; CELL LINE, TUMOR; CYCLOOXYGENASE 2; DINOPROSTONE; DNA PRIMERS; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENES, P53; HUMANS; KINETICS; NF-KAPPA B; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANS-ACTIVATION (GENETICS);

EID: 33748948050     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209579     Document Type: Article

References (56)

1. Barnas C, Martel-Planche G, Furukawa Y, Hollstein M, Montesano R, Hainaut P. (1997). Int J Cancer 71: 79-87.
2. Beltrami E, Plescia J, Wilkinson JC, Duckett CS, Altieri DC. (2004). J Biol Chem 279: 2077-2084.
3. Benoit V, Hellin AC, Huygen S, Gielen J, Bours V, Merville MP. (2000). Oncogene 19: 4787-4794.
4. Bentires-Alj M, Dejardin E, Viatour P, van Lint C, Froesch B, Reed JC et al. (2001). Oncogene 20: 2805-2813.
5. Bentires-Alj M, Hellin AC, Ameyar M, Chouaib S, Merville MP, Bours V. (1999a). Cancer Res 59: 811-815.
6. Bentires-Alj M, Merville MP, Bours V. (1999b). Drug Resist Updat 2: 274-276.
7. Birkenkamp-Demtroder K, Olesen SH, Sorensen FB, Laurberg S, Laiho P, Aaltonen LA et al. (2005). Gut 54: 374-384.
8. Bohuslav J, Chen LF, Kwon H, Mu Y, Greene WC. (2004). J Biol Chem 279: 26115-26125.
9. Buskens CJ, Sivula A, van Rees BP, Haglund C, Offerhaus GJ, van Lanschot JJ et al. (2003). Gut 52: 1678-1683.
10. Castellone MD, Teramoto H, Williams BO, Durey KM, Gutkind JS. (2005). Science 310: 1504-1509.
11. Corcoran CA, He Q, Huang Y, Sheikh MS. (2005). Oncogene 24: 1634-1640.
12. Das KC, White CW. (1997). J Biol Chem 272: 14914-14920.
13. Devary Y, Rosette C, DiDonato JA, Karin M. (1993). Science 261: 1442-1445.
14. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN. (1994). Gastroenterology 107: 1183-1188.
15. Gilroy DW, Saunders MA, Sansores-Garcia L, Matijevic-Aleksic N, Wu KK. (2001). FASEB J 15: 288-290.
16. Han JA, Kim JI, Ongusaha PP, Hwang DH, Ballou LR, Mahale A et al. (2002). EMBO J 21: 5635-5644.
17. Han JH, Roh MS, Park CH, Park KC, Cho KH, Kim KH et al. (2004). Mech Ageing Dev 125: 359-366.
18. Harris RE, Alshafie GA, Abou-Issa H, Seibert K. (2000). Cancer Res 60: 2101-2103.
19. Hla T, Bishop-Bailey D, Liu CH, Schaefers HJ, Trifan OC. (1999). Int J Biochem Cell Biol 31: 551-557.
20. Jeong SJ, Pise-Masison CA, Radonovich MF, Park HU, Brady JN. (2005). J Biol Chem 280: 10326-10332.
21. Jiang XH, Lam SK, Lin MC, Jiang SH, Kung HF, Slosberg ED et al. (2002). Oncogene 21: 6113-6122.
22. Jobin C, Morteau O, Han DS, Balfour SR. (1998). Immunology 95: 537-543.
23. Kaur BS, Khamnehei N, Iravani M, Namburu SS, Lin O, Triadafilopoulos G. (2002). Gastroenterology 123: 60-67.
24. Kaur BS, Triadafilopoulos G. (2002). Am J Physiol Gastrointest Liver Physiol 283: G327-G334.
25. Konturek PC, Nikiforuk A, Kania J, Raithel M, Hahn EG, Muhldorfer S. (2004). Dig Dis Sci 49: 1075-1083.
26. Krysan K, Dalwadi H, Sharma S, Pold M, Dubinett S. (2004a). Cancer Res 64: 6359-6362.
27. Krysan K, Merchant FH, Zhu L, Dohadwala M, Luo J, Lin Y et al. (2004b). FASEB J 18: 206-208.
28. Kuo KT, Chow KC, Wu YC, Lin CS, Wang HW, Li WY et al. (2003). Ann Thorac. Surg 76: 909-914.
29. Lagorce C, Paraf F, Vidaud D, Couvelard A, Wendum D, Martin A et al. (2003). Histopathology 42: 457-465.
30. Li N, Karin M. (1998). Proc Natl Acad Sci USA 95: 13012-13017.
31. Meyer M, Schreck R, Baeuerle PA. (1993). EMBO J 12: 2005-2015.
32. North S, Pluquet O, Maurici D, El Ghissassi F, Hainaut P. (2002). Mol Carcinog 33: 181-188.
33. Oshima M, Murai N, Kargman S, Arguello M, Luk P, Kwong E et al. (2001). Cancer Res 61: 1733-1740.
34. Rockwell P, Martinez J, Papa L, Gomes E. (2004). Cell Signal 16: 343-353.
35. Ryan KM, Ernst MK, Rice NR, Vousden KH. (2000). Nature 404: 892-897.
36. Sawaoka H, Kawano S, Tsuji S, Tsujii M, Gunawan ES, Takei Y et al. (1998). Am J Physiol 274: G1061-G1067.
37. Sengupta S, Harris CC. (2005). Nat Rev Mol Cell Biol 6: 44-55.
38. Sepehr A, Taniere P, Martel-Planche G, Zia'ee AA, Rastgar-Jazii F, Yazdanbod M et al. (2001). Oncogene 20: 7368-7374.
39. Shamma A, Yamamoto H, Doki Y, Okami J, Kondo M, Fujiwara Y et al. (2000). Clin Cancer Res 6: 1229-1238.
40. Shirvani VN, Ouatu-Lascar R, Kaur BS, Omary MB, Triadafilopoulos G. (2000). Gastroenterology 118: 487-496.
41. Siewert JR, Stein HJ. (1998). Br J Surg 85: 1457-1459.
42. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D et al. (1990). J Natl Cancer Inst 82: 1107-1112.
43. Smith GV, Feakins R, Farthing MJ, Ballinger A. (2005). Am J Clin Pathol 123: 415-420.
44. Steinbach G, Lynch PM, Phillips RK, Wallace MH, Hawk E, Gordon GB et al. (2000). N Engl J Med 342: 1946-1952.
45. Strano S, Fontemaggi G, Costanzo A, Rizzo MG, Monti O, Baccarini A et al. (2002). J Biol Chem 277: 18817-18826.
46. Subbaramaiah K, Altorki N, Chung WJ, Mestre JR, Sampat A, Dannenberg AJ. (1999). J Biol Chem 274: 10911-10915.
47. Subbaramaiah K, Dannenberg AJ. (2003). Trends Pharmacol Sci 24: 96-102.
48. Swamy MV, Herzog CR, Rao CV. (2003). Cancer Res 63: 5239-5242.
49. Tanabe T, Tohnai N. (2002). Prostaglandins Other Lipid Mediat 68-69: 95-114.
50. Tsuji S, Tsujii M, Kawano S, Hori M. (2001). J Exp Clin Cancer Res 20: 117-129.
51. Webster GA, Perkins ND. (1999). Mol Cell Biol 19: 3485-3495.
52. Wu KK, Liou JY, Cieslik K. (2005). Arterioscler Thromb Vasc Biol 25(4): 679-685.
53. Yang D, Welm A, Bishop JM. (2004). Proc Natl Acad Sci USA 101: 15100-15105.
54. Yu HP, Xu SQ, Liu L, Shi LY, Cai XK, Lu WH et al. (2003). Cancer Lett 198: 193-201.
55. Zhu Y, Saunders MA, Yeh H, Deng WG, Wu KK. (2002). J Biol Chem 277: 6923-6928.
56. Zimmermann KC, Sarbia M, Weber AA, Borchard F, Gabbert HE, Schror K. (1999). Cancer Res 59: 198-204.